HOME >> BIOLOGY >> NEWS
Patent awarded for LSUHSC-developed peptide that blocks lethal toxins of anthrax

New OrleansA patent has been awarded for a peptide developed by Dr. Iris Lindberg, Professor of Biochemistry at LSU Health Sciences Center in New Orleans, that blocks the lethal toxins of such infectious bacteria as Pseudomonas and anthrax. United States Patent #7,033,991was issued on April 25, 2006.

The peptide, called D6R (hexa-D-arginine amide), is a potent, stable, small molecule inhibitor of furin. Bacteria produce a number of toxins which rapidly enter and kill cells. In anthrax, the lethal factor toxin must bind to another part of the anthrax toxin, called the PA molecule, before it can enter and destroy a cell. But before binding can occur, the PA molecule produced by the bacteria must be made smaller. Furin, a protein-cutting enzyme or protease, which sits on the outside of cells, cuts the PA molecule, enabling the lethal factor toxin to attach to it. Lethal factor toxin cannot bind to PA that has not already been cut by furin; therefore, without cut PA, lethal factor toxin loses the ability to bind to and enter the cell, and becomes harmless.

Working on the theory that if the action of furin could be blocked, the toxins would not be activated and therefore unable to kill cells, the research team set out to make a peptide that would suppress furin activity. In collaboration with a research group in California (Torrey Pines Institute for Molecular Studies), the LSUHSC group developed the furin inhibitor, D6R. The LSUHSC research group working on anthrax under the direction of Dr. Iris Lindberg, Professor of Biochemistry, included past postdoctoral fellows Dr. Miroslav S. Sarac and Dr. Angus Cameron.

The LSUHSC research scientists examined the therapeutic potential of D6R against Pseudomonas aeruginosa exotoxin, both in cell culture and in live animals (mice). Various concentrations of D6R were tested, with no apparent side effects, regardless of dose. The survival rate of cells in culture 48 hours after treatment with D6Rgiven at the
'"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-452-9166
Louisiana State University Health Science Center
1-May-2006


Page: 1 2 3

Related biology news :

1. Patents for protein biomarker Discovery
2. Jan Lwe awarded 2007 EMBO Gold Medal
3. $9M grant awarded to University of Cincinnati for bipolar disorder research
4. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
5. CSHL awarded Pre-College Science Education Grant by HHMI
6. UD awarded $11M for osteoarthritis research and unique mentoring program for women scientists
7. UC Irvine awarded $3.9 million to upgrade stem cell research facilities, training
8. Computer science professor awarded $400,000 from National Science Foundation
9. Ocean observing contracts awarded to UC San Diego and University of Washington
10. Jaap Sinninghe Damst awarded the Vernadsky Medal for innovative use of biomarkers
11. Berkeley Lab Life Sciences division awarded NIH grants for fruit fly, nematode studies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
(Date:2/26/2017)... 2017  Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring, announces the appointment ... "Too often, too many offenders return to ... are trying to tackle this ongoing problem and ... family members. While significant steps are underway, Securus continues ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... at a Marketing Roundtable on March 22 in Philadelphia. The event was offered ... , The Marketing Roundtable featured breakout groups and interaction with speakers ...
(Date:3/28/2017)... WASHINGTON , March 28, 2017  (AACR17, ... single-cell sequencing during the American Association for Cancer Research ... Center in Washington, D.C. , April ... gene expression of thousands of cells at the individual ... Experts on-hand at AACR to discuss expanded ...
(Date:3/28/2017)... Dr. Chris Yu , Chief ... Anpac Bio-Medical Science Company , announced this week ... and reporting over 40,000 cases worldwide of the ... liquid biopsy tests. Described as "game ... Anpac Bio,s CDA medical devices and technology effectively ...
(Date:3/28/2017)... , March 28, 2017 ... and unpredictable sector due to the scientifically intensive ... include medical, agricultural, environmental, and industrial. In today,s pre-market ... Portola Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. (NASDAQ: ... Therapeutix Inc. (NASDAQ: OCUL ). Learn ...
Breaking Biology Technology:
Cached News: